A new pyridine-4,5-dichloroimidazol-2-ylidene complex of Ir(I) has been obtained, and its catalytic activity toward hydrosilylation of phenylacetylene and 4-aminophenylacetylene has been studied. The addition of HSiMe 2 Ph to the latter Ir(I) species afforded the corresponding Ir III -NHC hydrosilylated species, whose molecular structure was determined. This species and its nonchlorinated analogue have been used as catalyst of a series of reactions designed for elucidating the catalytic processes. The mechanism of the catalytic hydrosilylation of phenylacetylene has been studied by means of electrospray ionization mass spectrometry (ESI-MS) and tandem MS/MS, allowing the detection of all the reaction intermediates leading to both the hydrosilylation and the dehydrogenative-silylation products. The ratio of the silylation/hydrosilylation products depends on the excess of phenylacetylene added to the reaction mixture.
No takes yet. Share an insight, caveat, or question.
Vicent et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: